NanoVibronix Inc (OQ:NAOV)

Business Focus: Medical Equipment, Supplies & Distribution

Mar 28, 2024 08:30 am ET
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an agreement with Veranex, Inc. (“Veranex”) to assist with the development of the company’s next generation UroShield and PainShield products.
Feb 26, 2024 08:31 am ET
Thinking about buying stock in Intuitive Machines, SoundHound AI, Interactive Strength, Altimmune, or NanoVibronix?
NEW YORK, Feb. 26, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LUNR, SOUN, TRNR, ALT, and NAOV.
Dec 06, 2023 09:00 am ET
NanoVibronix Featured in Your Bladder Health Magazine
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield is featured in Issue 103 of Your Bladder Health Magazine in an article titled ‘UroShield Prevention is better than cure.’ The article highlights the effectiveness of using UroShield in the prevention of catheter associated urinary tract infections (CAUTIs). The article also includes testimonials that detail the positive impact that UroShield has had on the lives of p
Dec 04, 2023 09:00 am ET
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a non-binding letter of intent (the “LOI”) with APOGEPHA Arzneimittel GmbH (“APOGEPHA”) in which both parties will analyze the potential for APOGEPHA to distribute NanoVibronix’s premiere UroShield product in Germany and other European markets.
Nov 28, 2023 09:00 am ET
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (“RCT”) study of UroShield.
Nov 21, 2023 08:30 am ET
NanoVibronix Regains Nasdaq Compliance
NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on November 20, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compli
Nov 14, 2023 08:30 am ET
NanoVibronix Issues Letter to Shareholders
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a review of the third quarter 2023 and recent business developments.
Nov 07, 2023 08:30 am ET
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that effective November 1, its UroShield actuators are eligible for reimbursement on NHS Prescription Services’ Drug Tariff.
Sep 27, 2023 08:00 am ET
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its application for UroShield actuators to be available on NHS Prescription Services’ Drug Tariff has been approved.
Sep 06, 2023 08:30 am ET
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that Dr. Sandra Wilks is scheduled to present the findings from her study of UroShield® at the International Continence Society (ICS) 2023 Conference in Toronto on Wednesday, September 27.
Aug 30, 2023 02:29 pm ET
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,906,977 shares of its common stock (or common stock equivalents in lieu thereof), series A-1 warrants to purchase up to 2,906,977 shares of common stock and series A-2 warrants to purchase up to 2,906,977 shares of common stock, at a purchase price of $1.72 per share of common stock (or common stock
Aug 30, 2023 08:30 am ET
NanoVibronix Cites Positive Results from Independent Testing of UroShield
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today cited positive reported outcomes from a study of UroShield® that was conducted at the University of Southampton in the United Kingdom.
Aug 29, 2023 04:05 pm ET
NanoVibronix Responds to CMS’ Determination for PainShield
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today provided a response to the recently published payment determination by the Centers for Medicare & Medicaid Services (“CMS”) regarding the company’s PainShield device.
Aug 28, 2023 08:30 am ET
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today provided an update on its efforts to expand distribution of its UroShield family of products.
Aug 23, 2023 08:45 am ET
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has conditionally extended its distribution agreement with Ultra Pain Products, Inc. (“UPPI”) for the company’s PainShield® and PainShield Plus®.
Jun 14, 2023 08:30 am ET
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with Mio-Guard, LLC (“Mio-Guard”) for the sale and di
May 18, 2023 08:30 am ET
NanoVibronix Issues Letter to Shareholders
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a review of the first quarter 2023 and recent business
Apr 18, 2023 08:30 am ET
NanoVibronix Issues Letter to Shareholders
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a year in review and visio
Mar 28, 2023 08:30 am ET
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)
NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced that independent life expectancy testing performed by Carmel Labs in Israel confirm that its PainShield met all tested functionalities.
Mar 21, 2023 08:30 am ET
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced it has filed a new provisional patent application with the United States Patent and Trademark Office (“USPTO”) entitled “Multiple Frequency Surface Ac
Mar 14, 2023 09:15 am ET
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury
NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the positive evaluation results for its UroShield device, presented at a recent medical conference by clinicians from the Royal National Orthopa
Mar 03, 2023 08:30 am ET
NanoVibronix Regains Nasdaq Compliance
NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on February 28, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has
Feb 22, 2023 08:30 am ET
NanoVibronix to Launch Rental Program for PainShield and UroShield
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it intends to launch a month to month rental program on March 1, 2023 for its lead products, PainShield and UroShield.
Feb 08, 2023 12:00 pm ET
NanoVibronix Announces Reverse Stock Split
NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares. The reverse stock split will become effective at 4:05 p.m. on Wednesday, February 8, 2023. The Company’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol NAOV and will begin trading on a split-adjusted basis when the market opens on Thu
Jan 18, 2023 08:30 am ET
NanoVibronix Provides Update on Expanding Access to PainShield
NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided an update on the efforts to expand access to the Company’s PainShield product.
Dec 15, 2022 04:05 pm ET
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, announced that the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”) was held today virtually and broadcast live at
Dec 13, 2022 08:30 am ET
NanoVibronix Announces Partnership with Peak Medical, Ltd.
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it has partnered with Peak Medical, Ltd., a continence care patient focused company based in the United Kingdom.
Dec 01, 2022 02:06 pm ET
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules, of 4,80
Nov 29, 2022 08:07 am ET
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it has entered into a securities purchase agreement with several institutional investors for the purchase and
Nov 28, 2022 03:18 pm ET
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its PainShield® MD PLUS, its dual-actuator ultrasound pain therapy device.
Nov 16, 2022 08:30 am ET
NanoVibronix Announces Interim Results of Clinical Study for UroShield
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced interim results of its U.K. clinical study for UroShield that is being conducted by The University of Southampton and the National Biofilms Innovation Centre
Nov 15, 2022 08:33 am ET
NanoVibronix Provides Business Update in Letter to Shareholders
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update in a letter to shareholders from its Chief Executive Officer, Brian Murphy:
Oct 19, 2022 08:30 am ET
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that on October 17, 2022, a Nasdaq Hearings Panel (the “Panel”) granted the Company’s request for continued listing on The Nasdaq Capital Market (“Nas
Sep 23, 2022 10:50 am ET
Thinking about buying stock in Avenue Therapeutics, Color Star Technology, T2 Biosystems, NanoVibronix, or Energy Transfer?
NEW YORK, Sept. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATXI, CSCW, TTOO, NAOV, and ET.
Sep 23, 2022 08:30 am ET
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced its UroShield has been approved for sale by the U.K.’s National Health System’s (NHS) internal supply organization, NHS Supply Chain, through a new contract.
Sep 14, 2022 04:05 pm ET
NanoVibronix Sets Date for Annual Shareholder Meeting
NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), announced today that its annual meeting of shareholders (the “Annual Meeting”) will take place at 10 a.m. Eastern time on December 15, 2022. The Company will hold the Annual Meeting virtually via the internet.
Sep 14, 2022 09:25 am ET
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
NanoVibronix, Inc. (NASDAQ: NAOV) (“Nano” or the “Company”), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.001 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on October 14, 2022. The shares of Series F Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Time on October 17,
Sep 02, 2022 04:30 pm ET
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that, on August 30, 2022, the Company received notice from the Nasdaq Listing Qualifications Staff (the “Staff”
Aug 18, 2022 11:30 am ET
NanoVibronix Provides Business Update in Letter to Shareholders
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update in a letter to shareholders from its Chief Executive Officer, Brian Murphy:
Jul 12, 2022 08:30 am ET
NanoVibronix Announces Webinar Series to Promote UroShield
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced its Australian distributor, DukeHill HC, is launching a series of educational webinars to present the Company’s UroShield technology to clinicians. The seri
Jun 29, 2022 08:30 am ET
NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it is shifting the majority of its manufacturing operations to Singapore in order to allow scalability increase efficiency and address potential supply chain
May 17, 2022 08:30 am ET
NanoVibronix Reports First Quarter 2022 Financial Results
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today reported its financial results for the quarter ended March 31, 2022.
May 04, 2022 08:30 am ET
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its PainShield® MD PLUS, its dual-actuator ultrasound pai
Apr 25, 2022 08:30 am ET
NanoVibronix Adds Additional Product to Federal Supply Schedule
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its PainShield Plus and PainShield Monthly Kit products have been added to the Federal Supply Schedule (FSS) through a service dis
Apr 05, 2022 08:30 am ET
NanoVibronix Advances Efforts to Achieve NHS Approval
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has received the publication of Guidance from the
Mar 30, 2022 08:30 am ET
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the Company’s PainGuard and UroGuard, offered as private label products through Ideal Medical International Limited, have been approved by Health Canada / Santé Canada as licensed medical devices.
Feb 07, 2022 08:30 am ET
NanoVibronix Added an Additional National Payer Network in Workers’ Compensation Market
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a Provider Agreement with EZ Health Care. Under the terms of the agreement, NanoVibronix has been added to the EZ Workers’ Comp Network, making it easier for healthcare providers to file claims and be reimbursed when prescribing PainShield for patients being treated under a workers’ compensation plan.
Jan 24, 2022 08:30 am ET
NanoVibronix Extends Reach of UroShield and PainShield through MTSG’s International Network
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed an International Marketing, Sales and Clinical Management Agreement with Medtech Solutions Group (“MTSG”), a leader in the commercialization of healthcare technologies.
Jan 19, 2022 08:30 am ET
NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has filed three U.S. patent applications with the U.S. Patent & Trademark Office related to its SAW technology and indwelling medical devices to
Jan 13, 2022 08:30 am ET
NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced its board of directors has appointed Ms. Aurora (Rori) Cassirer and Ms. Maria (Lulu) Schroeder to serve as independent directors effective today.
Jan 07, 2022 01:02 pm ET
NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it will be featured as a presenting company at the H.C. Wainwright BioConnect Virtual Conference to be held January 10-13, 2022.
Jan 06, 2022 08:30 am ET
NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that Delta Medical, LLC, a Service-Disabled Veteran-Owned Small Business (“SDVOSB”) has been added to the company’s eco-system of distribution chan
Jan 05, 2022 08:30 am ET
NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has signed an agreement with Applied Medical Solutions, LLC (“AMS”) for the sale and distribution of its PainShield products to Veteran
Dec 21, 2021 10:30 am ET
NanoVibronix Adjourns Special Meeting of Stockholders
NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) announced today that the Company’s Special Meeting of Stockholders, scheduled for 10:00 a.m. Eastern time today, December 21, 2021, has been adjourned to allow for more time for stockholders to vote...
Dec 21, 2021 08:00 am ET
NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has commenced sales in Europe with the signing of a distribution agreement with Medina Healthcare Ltd (“Medina”) in Malta.
Dec 08, 2021 08:30 am ET
NANOVIBRONIX TO SHOWCASE PAINSHIELD PRODUCTS AT 75TH ANNUAL WORKERS’ COMPENSATION EDUCATIONAL CONFERENCE DECEMBER 12-15
NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it will showcase its PainShield products at the...
Dec 07, 2021 08:30 am ET
NanoVibronix Announces Encouraging Interim Results in Real World Patient Study of UroShield
NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive interim results from an independent, real...
Dec 02, 2021 05:30 am ET
NanoVibronix Announces Early Success in the Marketing of Painshield to Veteran’s Administration Healthcare Providers
NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that sales of its Painshield device to the Veterans...
Nov 16, 2021 08:30 am ET
NanoVibronix Reports Third Quarter 2021 Financial Results
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today reported its financial results for the quarter ended September 30, 2021.
Oct 28, 2021 09:28 am ET
NanoVibronix CEO Brian Murphy Provides Business Update in Letter to Shareholders
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update and letter to shareholders from its...
Oct 11, 2021 10:55 am ET
Thinking about buying stock in Camber Energy, NanoVibronix, Progenity, Marathon Oil, or Bit Digital?
NEW YORK, Oct. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, NAOV, PROG, MRO, and BTBT.
Oct 11, 2021 09:06 am ET
NANOVIBRONIX ANNOUNCES POSITIVE RESULTS FROM INDEPENENT, DOUBLE-BLIND TRIAL OF PAINSHIELD
NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive results from a randomized, double-blind...
Sep 29, 2021 10:14 am ET
NANOVIBRONIX ENTERS WORKER’S COMPENSATION MARKET THROUGH AGREEMENT WITH ORCHID MEDICAL
NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered the worker’s compensation market with...
Sep 14, 2021 08:30 am ET
NANOVIBRONIX EXTENDS LINE-UP OF PAIN MANAGEMENT PRODUCTS
NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it is launching a new, transdermal gel containing...
Aug 18, 2021 10:50 am ET
Thinking about buying stock in Sesen Bio, NanoVibronix, Tencent Music Entertainment, New Oriental Education, or Ford Motor?
NEW YORK, Aug. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SESN, NAOV, TME, EDU, and F.
Aug 17, 2021 02:32 pm ET
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, announced that the Company’s Annual Meeting of Stockholders was held today virtually and b
Aug 17, 2021 10:50 am ET
Thinking about buying stock in NanoVibronix, Advanced Micro Devices, Romeo Power, Futu Holdings, or AcelRx Pharmaceuticals?
NEW YORK, Aug. 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAOV, AMD, RMO, FUTU, and ACRX.
Aug 16, 2021 04:05 pm ET
NanoVibronix Reports Second Quarter 2021 Financial Results; Provides Business Update
NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today reported its financial results for the quarter ended June 30,...
Aug 16, 2021 10:55 am ET
Thinking about buying stock in NanoVibronix, ContextLogic, SoFi Technologies, Toughbuilt Industries, or FuelCell Energy?
NEW YORK, Aug. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAOV, WISH, SOFI, TBLT, and FCEL.
Aug 16, 2021 08:30 am ET
NANOVIBRONIX ANNOUNCES PLAN TO EXPAND PRODUCT PORTFOLIO WITH INTRODUCTION OF PAINSHIELD RELIEF FOR OVER-THE-COUNTER (OTC) USE AND PLANS FOR FUTURE PRODUCT LAUNCH
NanoVibronix, Inc., (NASDAQ: NAOV), a Healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it intends to enter the Over-the-Counter (OTC)...
Aug 13, 2021 10:50 am ET
Thinking about buying stock in SoFi Technologies, NanoVibronix, Fisker, Opendoor Technologies, or Bit Digital?
NEW YORK, Aug. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SOFI, NAOV, FSR, OPEN, and BTBT.
Aug 12, 2021 11:00 am ET
Thinking about buying stock in Micron, NanoVibronix, OncoCyte, PG&E Corp, or CohBar?
NEW YORK, Aug. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MU, NAOV, OCX, PCG, and CWBR.
Aug 11, 2021 08:30 am ET
NANOVIBRONIX RECEIVES REGISTRATION APPROVAL FOR PAINSHIELD FROM TGA AUSTRALIA
NanoVibronix, Inc., (NASDAQ: NAOV), a Healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Therapeutic Goods Administration (TGA), The...
Aug 05, 2021 11:00 am ET
Thinking about buying stock in NanoVibronix, Castor Maritime, General Motors, Bit Digital, or Veoneer?
NEW YORK, Aug. 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAOV, CTRM, GM, BTBT, and VNE.
Aug 05, 2021 08:52 am ET
NanoVibronix Applies for CMS Reimbursement Code for UroShield® and PainShield Plus®
NanoVibronix, Inc., (NASDAQ: NAOV), a Healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the company has completed the application process with the Centers for Medicare and Medicaid (CMS) to receive a reimbursement code for its U
Aug 02, 2021 11:25 am ET
Thinking about buying stock in Ever-Glory, NanoVibronix, General Electric, Allied Healthcare, or Nikola?
NEW YORK, Aug. 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EVK, NAOV, GE, AHPI, and NKLA.
Jul 30, 2021 10:55 am ET
Thinking about buying stock in Erytech Pharma, NanoVibronix, Atossa Therapeutics, Allied Healthcare, or Camber Energy?
NEW YORK, July 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ERYP, NAOV, ATOS, AHPI, and CEI.
Jul 29, 2021 10:50 am ET
Thinking about buying stock in NanoVibronix, TAL Education, Cleveland-Cliffs, Nikola Corp, or Acer Therapeutics?
NEW YORK, July 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAOV, TAL, CLF, NKLA, and ACER.
Jul 29, 2021 09:00 am ET
NanoVibronix Receives Registration Approval for UroShield From TGA Australia
NanoVibronix, Inc., (NASDAQ: NAOV), a Healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Therapeutic Goods Administration (TGA), The Australian Regulatory body for Therapeutic Devices, has granted approval for its UroShi
Jul 26, 2021 10:47 am ET
NanoVibronix Ships First Order of PainShield Plus
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today announced it has fulfilled the first order of its next generation pain management device, PainShield Plus®, and expects to recognize revenue for th
Jul 22, 2021 08:15 am ET
NanoVibronix Announces Publication of Compelling Study Results for UroShield in The Journal of Medical & Surgical Urology
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today announced that The Journal of Medical & Surgical Urology is...
Jun 03, 2021 08:30 am ET
NanoVibronix Provides Business Update
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today provided an update on its business. Received CMS Approval for...
Apr 27, 2021 11:17 am ET
NanoVibronix Adjourns Special Meeting of Stockholders
NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) announced today that the Company’s Special Meeting of Stockholders, which had been previously adjourned to 10:00 a.m. Eastern time today, April 27, 2021, has been once again adjourned to allow for...
Apr 26, 2021 09:00 am ET
NanoVibronix Announces Expanded CMS Reimbursement Approval for PainShield
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the U.S. Centers for Medicare and...
Apr 19, 2021 09:50 am ET
NanoVibronix Announces Start of Real World Patient Study of UroShield
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that an independent, real world patient study of its UroShield has commenced at Southampton University Health Sciences in par
Apr 14, 2021 12:57 pm ET
NanoVibronix Adjourns Special Meeting of Stockholders
NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) announced today that the Company’s Special Meeting of Stockholders, which had been previously adjourned to 10:00 a.m. Eastern time today, April 14, 2021, has been once again adjourned to allow for...
Mar 31, 2021 06:50 pm ET
NanoVibronix Adjourns Special Meeting of Stockholders
NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) announced today that the Company’s Special Meeting of Stockholders, scheduled for 10:00 a.m. Eastern time today, March 31, 2021, has been adjourned to allow for more time for stockholders to vote. The meeting has been scheduled to reconvene on April 14, 2021 at 10:00 a.m. Eastern time and will be held virtually online at
Mar 02, 2021 08:30 am ET
NanoVibronix UroShield Joins PainShield on Federal Supply Schedule, Expanding Access to VA Market
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield urology therapy device has been added to the Federal Supply Schedule through a service disabled veteran organizat
Feb 10, 2021 08:00 am ET
NanoVibronix Reports Schedule Published by NICE for Review of UroShield® Device
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has received documentation from the
Feb 03, 2021 08:00 am ET
NanoVibronix Regains Nasdaq Compliance
In addition, on January 4, 2021 the company received notice from Nasdaq that it has regained compliance with the equity requirement under Nasdaq Listing Rule 5550(b)(1).
Jan 19, 2021 08:00 am ET
NanoVibronix Issues Letter to Shareholders
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a year in review and vision for 2021.
Dec 11, 2020 08:00 am ET
NanoVibronix Amends and Expands Distribution Agreement for Its PainShield® and PainShield Plus®
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc. (
Dec 08, 2020 08:00 am ET
NanoVibronix Announces UroShield and PainShield Meet New Zealand Medicines and Medical Devices Safety Authority Regulatory Requirements
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield and PainShield meet the New Zealand Medical Devices Safety Authority regulatory requirements and have been
Dec 07, 2020 05:10 pm ET
NanoVibronix Announces Closing of $6.0 Million Private Placement Priced At-the-Market
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the closing of its previously announced private placement of 8,571,429 shares of common stock (or common stock equivalents) at a purchase price of $0.70 per share that was priced “at-the-market” under Nasdaq Rules and resulted in gross proceeds of approximately $6.0 million before the deduction of placement agent fees and expenses and estimated offering expenses payable by the Company.
Dec 02, 2020 01:01 pm ET
NanoVibronix Announces $6.0 Million Private Placement
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into securities purchase agreements with certain institutional and accredited investors to raise $6.0 million through the issuance of 8,571,429 shares of its common stock (or common stock equivalents) at a purchase price of $0.70 per share in a private placement. The closing of the private placement is expected to occur on or about December 4, 2020, subject to satisfaction
Dec 02, 2020 07:54 am ET
Independent Study Finds Significant Benefits Provided by NanoVibronix’s UroShield® Device
“Findings from an independent study demonstrate significant benefits of our UroShield device with patients reporting reductions in blockages, catheter changes and use of bladder maintenance solutions in addition to reductions in pain, fewer visits to clinics and hospitals for emergency catheter changes,” stated Brian Murphy, CEO of NanoVibronix. “As part of our ongoing engagement, we submitted these findings to NICE as part of the process for attaining ‘official guidance’ from the organization, an important step in providing access to all NHS patients at risk of catheter associated urinary tra
Nov 16, 2020 06:12 pm ET
NanoVibronix Reports Third Quarter 2020 Financial Results, Provides Business Update
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today reported its financial results for the quarter ended September 30, 2020 and provided a business update.
Oct 16, 2020 08:30 am ET
NanoVibronix Expands Offerings with Introduction of PainShield Plus®
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the launch of the next generation of its ultrasound pain management device, PainShield Plus® for the treatment of m
Oct 08, 2020 09:00 am ET
NanoVibronix Receives Positive Nasdaq Listing Determination
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Company has received formal notification that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Capital Market pursuant to an extension through December 15, 2020, to evidence compliance with the minimum $2.5 million stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b) for continued list
Jul 07, 2020 08:00 am ET
NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield
ELMSFORD, N.Y., July 7, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that effective June 22, 2020, it has entered into a two-year exclusive agreement with Ultra Pain Products, Inc. ("UPPI") for the distribution of NanoVibronix's proprietary PainShield™ devices and components through and by Durable Medical Equipment (DME) Distributors throughout the United States.
Jun 16, 2020 08:00 am ET
NanoVibronix Fulfills its First Private Label Partnership with Medisana and Receives Award for PainShield PT 100 Quality
ELMSFORD, N.Y., June 16, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces Surface Acoustic Wave (SAW) based Ultrasonic Therapeutic Devices - the UroShield®, PainShield® and WoundShield®, today announced that its newly introduced PainShield PT 100 ultrasound therapy device has received the coveted Plus X Award 2020 in the categories of high quality, design, ease of use and functionality. 
Jun 01, 2020 08:00 am ET
NanoVibronix Expands License Agreement for UroShield® and PainShield™ with Existing Distributor to Include Canada and Turkey
ELMSFORD, N.Y., June 1, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has expanded its license agreement with Ideal Medical International Limited to include exclusive rights to distribute the Company's UroShield® and PainShield® technologies in Canada and Turkey effective May 27, 2020. 
Apr 02, 2020 11:06 am ET
SANUWAVE Health Announces Exclusive Licensing of NanoVibronix, Inc. Surface Acoustic Wave Ultrasound Technology
via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) and NanoVibronix, Inc. have announced an exclusive worldwide license agreement for NanoVibronix’s surface acoustic wave ultrasound technology in the wound care market.  Under this...
Apr 02, 2020 08:00 am ET
NanoVibronix Announces License Agreement for WoundShield Product
ELMSFORD, N.Y., April 2, 2020 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it signed a license agreement with Sanuwave Health, Inc. for the manufacture and delivery of its WoundShield technology. 
Apr 01, 2020 08:00 am ET
NanoVibronix Receives Reimbursement Approval from U.S. Centers for Medicare & Medicaid Services (CMS) for PainShield™
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has...
Mar 27, 2020 09:41 am ET
NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device which attaches to an indwelling catheter and has been clinically proven to mitigate...
Dec 10, 2019 11:45 am ET
NanoVibronix, Inc. to Present at the Investor Summit on December 17th in Philadelphia
PHILADELPHIA, PA / ACCESSWIRE / December 10, 2019 / NanoVibronix, Inc. (NASDAQ:NAOV), will be presenting at this year's Investor Summit on December 17th in Philadelphia.
Sep 03, 2019 08:30 am ET
NanoVibronix and Marathon Medical to Provide PainShield to VA Hospitals and the Department of Justice
ELMSFORD, N.Y., Sept. 3, 2019 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, announces on August 18th, 2019, PainShield, and PainShield Supplies were added to the Federal Supply Schedule through NanoVibronix' relationship with Marathon Medical, a Service Disabled Veteran Owned Small Business (SDVOSB) headquartered in Aurora, Colorado. Accordingly, Marathon Medical can now sell PainShield and related supplies to the Veterans Health Administration, the largest integr
Aug 27, 2019 08:30 am ET
NanoVibronix Reports Significant Progress with a Leading Global Consumer Healthcare Company
ELMSFORD, N.Y., Aug. 27, 2019 /PRNewswire/ -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, today announced significant progress with a leading global consumer healthcare company, Medisana, which has resulted in an initial Original Equipment Manufacturing (OEM) purchase order. The Company will commence the manufacture of a specialized product for Medisana based on its PainShield® device called the PT-100. The product will be sold directly and exclusively via Medisana.
Jul 23, 2019 08:30 am ET
NanoVibronix Announces License Agreement with Ideal Medical International Limited for International Distribution of PainShield(R) and UroShield(R)
ELMSFORD, NY / ACCESSWIRE / July 23, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that i
Jun 24, 2019 05:42 pm ET
NanoVibronix Announces Closing of $3.2 Million Private Placement
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that it...
Jun 19, 2019 09:20 am ET
NanoVibronix Announces Presentation of PainShield(R) to HCPCS Workgroup at CMS
ELMSFORD, NY / ACCESSWIRE / June 19, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company's proprietary and patented low intensity, SAW ultrasound technology, announces that on June 12, 2019, the Company had the opportunity to present their signature product, PainShield® surface acoustic wave device, to the Healthcare Common Procedure Coding System (HCPCS) Workgroup at the Centers for Medicare &
Jun 14, 2019 09:00 am ET
NanoVibronix Announces Rescheduling of Annual Meeting of Stockholders
ELMSFORD, NY / ACCESSWIRE / June 14, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company's proprietary and patented low intensity, SAW ultrasound technology, announces that the Company's 2019 Annual Meeting of Stockholders, originally scheduled for 10:00 a.m. Eastern Time yesterday, June 13, 2019, was adjourned due to the lack of the requisite quorum. The meeting has been rescheduled for June 20,
Jun 05, 2019 08:30 am ET
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced that it...
Jun 03, 2019 09:00 am ET
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield(R) Designed to Amplify Therapeutic Effect
- Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain- NanoVibronix partnering with Saralex Group for regulatory approval and global distribution
May 24, 2019 08:00 am ET
NanoVibronix Provides Business Update for the First Quarter of 2019
ELMSFORD, NY / ACCESSWIRE / May 24, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the first quarter ended March 31, 2019.
Apr 02, 2019 08:00 am ET
NanoVibronix Provides Year-End Business Update
Reports on Commercial Progress for both PainShield® and UroShield®
Mar 25, 2019 09:00 am ET
NanoVibronix Announces Reimbursement Approvals for PainShield(R) in the U.S.
Reimbursement aligned with AHIP and CMS initiatives to help combat the opioid epidemic
Mar 20, 2019 08:00 am ET
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy
ELMSFORD, NY / ACCESSWIRE / March 20, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an exclusive agreement with N.B.A. medica s.r.l. to market and distribute NanoVibronix's PainShield® and UroShield in Italy.
Mar 08, 2019 09:00 am ET
NanoVibronix CEO to Present UroShield(R) at the U.S. National Institutes of Health's Catheter-Associated Urinary Tract Infections Technology Workshop
ELMSFORD, NY / ACCESSWIRE / March 8, 2019 / NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing its proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that CEO Brian Murphy will present UroShield® at the Catheter-Associated Urinary Tract Infections Technology Workshop hosted by National Institutes of Health (NIH) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) on Monday, March 11, 2019 at the NIH's Natcher Conference Center in Bethesda, Maryland.
Mar 07, 2019 08:30 am ET
NanoVibronix Reports Positive Interim Tennis Elbow Study Results Using PainShield(R)
ELMSFORD, NY / ACCESSWIRE / March 7, 2019 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced results of a study entitled, "The Effects of the NanoVibronix's PainShield® Surface Acoustic Waves on the Symptoms of Lateral Epicondylitis." The clinical study was conducted by Dr. David Lemak, a leading orthopedic surgeon with Birmingham Orthopedic and Sports Specialists.
Mar 04, 2019 08:30 am ET
NanoVibronix Launches New Consumer and Industry Focused Website Highlighting Advantages of PainShield, UroShield and WoundShield
ELMSFORD, NY / ACCESSWIRE / February 4, 2019 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has launched a new website (www.nanovibronix.com) designed to highlight the advantages of the Company's proprietary and patented low intensity surface acoustic wave (SAW) devices, including PainShield®, UroShield® and WoundShield®.
Feb 25, 2019 08:00 am ET
NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain Research
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the publication of an independent study entitled, “The Effect of a...
Jan 11, 2019 08:00 am ET
NanoVibronix Enters Collaboration Agreement with Fritz Clinic to Offer PainShield® as an Alternative to Opioids for Pain Management
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it has entered into a collaboration agreement with the Fritz...
Dec 27, 2018 08:00 am ET
NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has expanded its distribution agreement with MDS. Pharm Ltd.,...
Dec 20, 2018 08:00 am ET
NanoVibronix Signs Major Distributor in India for UroShield®
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced, in partnership with Morulaa HealthTech, NanoVibronix’s marketing...
Dec 18, 2018 09:25 am ET
NanoVibronix Signs with Exclusive Distributor in Switzerland for UroShield®
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed a new distribution agreement for UroShield® with...
Dec 11, 2018 09:01 am ET
NanoVibronix Announces Selection of Leading International Contract Manufacturer to Support Rapid Scale-up, Lower Price Points and Enhance Profitability
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has appointed Quasar as its contract manufacturer for the...
Dec 06, 2018 08:00 am ET
NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections
UroShield™ reduced Colony Forming Units (CFU) count from >- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the...
Nov 19, 2018 07:50 am ET
New Research: Key Drivers of Growth for Nanovibronix, Griffin Industrial Realty, Iteris, NAPCO Security Technologies, Nortech, and New Age Beverage — Factors of Influence, Major Initiatives and Sustai
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Nanovibronix, Inc. (NASDAQ:NAOV), Griffin Industrial Realty, Inc....
Nov 14, 2018 08:00 am ET
NanoVibronix Provides Business Update for the Third Quarter of 2018
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the third quarter ended September 30, 2018....
Oct 22, 2018 04:47 pm ET
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, Chief Executive Officer, will be presenting at...
Oct 22, 2018 04:12 pm ET
NanoVibronix CEO Brian Murphy and Former MLB Pitcher Bret Saberhagen to Appear Today on Varney & Co. on Fox Business to Discuss PainShield
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix, and former MLB pitcher, Bret...
Aug 16, 2018 08:00 am ET
NanoVibronix Provides Business Update for the Second Quarter of 2018
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the second quarter ended June 30, 2018. Brian...
Jul 24, 2018 07:30 am ET
NanoVibronix Reports Successful Trial Results for Use of PainShield™ in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced successful results for its PainShield™ device in treating patients...
Jun 05, 2018 07:00 am ET
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield® and WoundShield® in Israel
NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an exclusive agreement with M.D.S. Pharm Ltd. to...
May 17, 2018 09:44 am ET
NanoVibronix Provides Business Update for the First Quarter 2018
NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the first quarter of 2018. Brian Murphy, Chief...
May 09, 2018 07:00 am ET
NanoVibronix Partners with Fabrication Enterprises, Inc. for Distribution of PainShield® in the United States
NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has partnered with Fabrication Enterprises, Inc. to market and...
May 01, 2018 08:39 am ET
NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3rd...
Apr 05, 2018 07:30 am ET
NanoVibronix Announces Instrumed Surgical as its Exclusive Canadian Distributor for UroShield(TM)
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed Instrumed Surgical of Mississauga, Ontario, Canada as...
Apr 02, 2018 07:00 am ET
NanoVibronix Provides Year-End 2017 Business Update and Files 10-K
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the year ended December 31, 2017.Brian Murphy,...
Mar 21, 2018 03:40 pm ET
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera Appear on Fox News Radio's The Brian Kilmeade Show to Discuss PainShield's Advantages and Potential to Reduce Opioid Use
NanoVibronix Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees pitcher...
Mar 21, 2018 08:01 am ET
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera to Appear on Fox Business Network's Mornings with Maria to Discuss the Role of PainShield in Fighting the Opioid Epidemic
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees pitcher...
Mar 01, 2018 07:30 am ET
NanoVibronix Announces Positive Response to UroShield(TM) Presentation at the Infection Prevention and Control 2018 London Conference
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology today announced that Dr. Harold Jacob, M.D., Chief Medical Officer of NanoVibronix, led...
Jan 22, 2018 07:30 am ET
NanoVibronix to Present at the 14th Annual Noble Capital Markets Investor Conference
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, will present at NobleCon14 - Noble Capital Markets' Fourteenth Annual Investor...
Jan 19, 2018 01:06 pm ET
NanoVibronix CEO Brian Murphy Appears on Varney & Co. on Fox Business; Comments on Role of PainShield in Fighting Opioid Epidemic
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix, appeared as a guest on Varney...
Jan 18, 2018 10:00 am ET
Dec 21, 2017 09:41 am ET
NanoVibronix CEO Brian Murphy Provides Business Update Letter to Shareholders
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update and letter to shareholders from its Chief...
Dec 20, 2017 09:00 am ET
NanoVibronix Announces Morulaa HealthTech as its Regulatory & Marketing Partner in India
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed Morulaa HealthTech as its regulatory and marketing...
Dec 14, 2017 07:30 am ET
NanoVibronix Announces IMS Ultrasound (UK) Ltd as its Exclusive UK Distributor for UroShield(TM) Following Successful Interim Trial Results
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed IMS Ultrasound (UK) Ltd as its exclusive distributor...
Dec 06, 2017 12:20 pm ET
Wildfire Forces Cancellation of LD Micro Conference
Presentations Canceled for Celsius Holdings, Inc., GSI Technology, Inc., PCM, Inc., Simulations-Plus, ADOMANI, Inc., HUTN, Inc., NanoVibronix, Inc. and WidePoint Corp.
Dec 05, 2017 08:00 am ET
NanoVibronix Announces Exclusive UK Distributor for PainShield(TM) Providing Patients an Alternative to Opioids and Surgery
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed BHR Pharmaceuticals Ltd., a leading distributor of...
Nov 29, 2017 07:30 am ET
NanoVibronix Reports Successful Interim Trial Results for Use of PainShield(TM) in Patients with Trigeminal Neuralgia; Represents Potential Alternative to Opioid and Surgical Interventions
NanoVibronix Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced successful interim trial results for its PainShield™ device in treating...
Nov 14, 2017 07:50 am ET
NanoVibronix to Commence Trial of Anti-Aging Device in Collaboration with Global Cosmetics Company
NanoVibronix, Inc. (NASDAQ: NAOV),a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the execution of a collaborative agreement to conduct a single-center...
Nov 08, 2017 07:30 am ET
NanoVibronix Announces Successful Interim Trial Results for UroShield(TM)
NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced successful interim trial results for its UroShield™ device. UroShield™ is an...
Nov 07, 2017 10:13 am ET
NanoVibronix Announces Closing of $6,000,000 Public Offering
NanoVibronix, Inc. ("NanoVibronix" or the "Company") (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced the closing of an underwritten public...
Nov 01, 2017 09:53 pm ET
NanoVibronix Announces Pricing of $6,000,000 Public Offering
NanoVibronix, Inc. ("NanoVibronix" or the "Company") (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced the pricing of an underwritten public...
Jul 12, 2017 07:30 am ET
NanoVibronix Announces Successful Interim Trial Results for UroShield(TM)
NanoVibronix, Inc, (OTCQB: NAOV ), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced successful interim trial results for UroShield™. UroShield™ is an...
May 26, 2017 09:00 am ET
IDW Media Holdings Names Stephen R. Brown to Board of Directors
IDW Media Holdings, Inc. (OTCQX: IDWM) is pleased to announce that, on May 22, 2017, Stephen R. Brown joined its Board of Directors. Since October 2016, Mr. Brown has served as the President of GMA Fund, LLC, a specialty finance company, and, since February 2015, has served as the Chief Financial Officer of Nanovibronix, Inc. (OTCBB: NAOV). In addition, since 2009, Mr. Brown has been the managing partner of The McGuffin Group Financial, a financial consulting firm concentrating on advising early-stage companies.
Mar 09, 2017 07:30 am ET
US Patent and Trademark Office Grants Patent to NanoVibronix for Surface Acoustic Wave Technology
NanoVibronix, Inc. (OTCQB: NAOV),a medical device company, today announced that it has been granted a patent by the United States Patent and Trademark Office entitled, "System and Method for Surface Acoustic Wave Treatment of Skin," with a term...
Jan 09, 2017 07:30 am ET
NanoVibronix Announces Abstract Acceptance and Presentation at the European Association of Urology's 32nd Anniversary EAU Congress
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, today announced that its abstract, entitled "Surface acoustic waves prevent bacterial colonization in indwelling urinary catheters," has been accepted for presentation at the European...
Dec 28, 2016 07:30 am ET
NanoVibronix Receives Health Canada Approval to Sell WoundShield(TM) in Canada
NanoVibronix, Inc. (OTCQB: NAOV), a medical device company, today announced that it has received clearance to sell the WoundShield™ in Canada. The WoundShield™ system is a novel, patch-based therapeutic ultrasound device that facilitates soft tissue...
Dec 22, 2016 07:30 am ET
NanoVibronix Reports Progress on Three Clinical Trials
NanoVibronix, Inc., (OTCQB: NAOV), a medical device company, today provided an update on three significant clinical trials for its PainShield™, UroShield™ and TrachShield™ devices. Studies are underway in the U.S. and in Israel in order to...
Nov 15, 2016 07:00 am ET
NanoVibronix Provides Third Quarter 2016 Business Update
NanoVibronix, Inc. (OTCQB: NAOV), a medical device company, today has issued a business update on the company's patented low intensity surface acoustic wave technology for pain management, wound healing and other indications.Brian Murphy, Chief...
Oct 20, 2016 07:30 am ET
NanoVibronix Expands Senior Management Team and Board of Directors
NanoVibronix, Inc. (OTCQB: NAOV), a medical device company, today announced an expansion of the senior management team and Board of Directors. The Company appointed Brian M. Murphy as Director and Chief Executive Officer and Christopher M. Fashek as...
Sep 28, 2016 07:30 am ET
NanoVibronix Announces Distribution Agreement With Mano Equestrian Services (PTE) LTD in Singapore for Equine PainShield(R)
NanoVibronix, Inc, (OTCQB: NAOV),a medical device company, today announced a distribution agreement with Mano Equestrian Services (PTE) LTD ("Mano") to market and distribute Equine PainShield® in Singapore. Mano's distribution network covers...
Sep 19, 2016 07:01 am ET
Emerging Markets Report: Follow a Northern Star
ORLANDO, Fla., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Followers of biotechnology stocks and Durable Medical Equipment (DME) companies are often honed in on two driving forces, regulatory approvals and new sales markets. Innovative medical device maker NanoVibronix, Inc, (OTCQB:NAOV) might have just delivered their investors both with a potentially larger opportunity awaiting its own possible approval....
Sep 06, 2016 07:30 am ET
NanoVibronix Receives Health Canada Approval to Sell UroShield(TM) in Canada
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, today announced that NanoVibronix has received clearance to sell the UroShield™ in Canada. UroShield™ is effective in preventing Urinary Tract Infections (UTI) in patients with indwelling...
Aug 08, 2016 07:00 am ET
Emerging Markets Report: 2.6 Million Reasons
ORLANDO, Fla., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Savvy investors are aware of many of the perils besieging small cap companies and potentially the value of their investments. Foremost among these concerns is a share structure that continues to grow, often driven by convertible debt and other financial actions that lead to adverse valuations for the public....
Aug 02, 2016 07:30 am ET
Retired NFL Quarterback Vinny Testaverde Endorses NanoVibronix's SPORT Painshield(TM)
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, announced today that Vinny Testaverde, retired quarterback who played 21 seasons in the NFL and Heisman trophy winner, has endorsed NanoVibronix's SPORT Painshield™ for relief of joint and...
Mar 30, 2016 09:00 am ET
NanoVibronix Provides Business Update on Its Proprietary and Patented Low Intensity Surface Acoustic Wave Technology That Targets Wound Healing and Pain Therapy
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, today has issued a business update on the company's patented low intensity surface acoustic wave technology for pain management, wound healing and other indications.William Stern, PhD,...
Mar 22, 2016 07:30 am ET
Israeli Patent Office Issues Notice of Allowance to NanoVibronix Allowing All Claims of Patent Application for System and Method for Surface Acoustic Wave Treatment of Skin
NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, has announced that the Israeli Patent Office has issued a notice of allowance for our system and method for surface acoustic wave treatment of skin. The patent will be granted following...
Feb 25, 2016 01:18 pm ET
NanoVibronix Announces Favorable Response to Presentation at the American Academy of Pain Medicine 32nd Annual Meeting at the Palms Springs Convention Center in California
NanoVibronix, Inc, (OTCQB: NAOV), developer of the patented low intensity surface acoustic wave technology for pain management, wound healing and other indications, today announced that its PainShield®, for chronic and acute pain and sports...
Feb 18, 2016 02:33 pm ET
NanoVibronix to Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach
NanoVibronix, Inc., (OTCQB: NAOV), a medical device company, today announced that William Stern, PhD, Chief Executive Officer of NanoVibronix will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.